Ryan Van Laar Ph.D. Email & Phone Number
@signalgenetics.com
3 phones found area 212 and 140
LinkedIn matched
Who is Ryan Van Laar Ph.D.? Overview
A concise factual answer block for searchers comparing this professional profile.
Ryan Van Laar Ph.D. is listed as Founder and CEO at Geneseq Biosciences Pty Ltd, based in Melbourne, Victoria, Australia. AeroLeads shows a work email signal at signalgenetics.com, phone signal with area code 212, 140, and a matched LinkedIn profile for Ryan Van Laar Ph.D..
Ryan Van Laar Ph.D. previously worked as Founder & CEO at Geneseq Biosciences Pty Ltd and Laboratory Director, Vice President, Research and Operations at Signal Genetics, Inc. Ryan Van Laar Ph.D. holds Postgraduate Certificate, Biostatistics from University Of Melbourne.
Email format at Geneseq Biosciences Pty Ltd
This section adds company-level context without repeating Ryan Van Laar Ph.D.'s masked contact details.
AeroLeads found 1 current-domain work email signal for Ryan Van Laar Ph.D.. Compare company email patterns before reaching out.
About Ryan Van Laar Ph.D.
I am a biologically-oriented genomics specialist, with over 20 publications, 2 issued US patents, 3 commercialized assays and 2 FDA clearances under my belt. My primary area of focus has been in the field of oncology and molecular diagnostics. I am fortunate to have participated in all stages of developing and delivering advanced genomic assays (including array and NGS assessment of DNA, RNA and microRNA) and am driven by a desire use technology to help patients TODAY, not in 20 years time.Background: PhD from the University of Melbourne (Australia) after an Honors degree in Biotechnology from Deakin University. I hold a Certificate of Qualification from New York State to supervise multi-gene oncology assays and have been involved coordinating several successful FDA IDE and PMA/510k clearances for novel diagnostic products. In 2010 I developed a web-based platform for high-throughput, user-driven genomic analysis of microarray data (www.ChipDX.com). This system was acquired by Signal Genetics in 2012 and is now in use for a number of clinical diagnostic applications. Specialties: - Genomic assay design, validation, publication, quality control, SOP development, sales training & reimbursement support- Build-out of laboratory and bioinformatics capabilities- Hiring, training and supervision of bioinformatics and laboratory staff- Statistical data analysis - survival analysis, hypothesis testing, multivariate regression- Scientific manuscript preparation,- Biomarker and novel target identification from proprietary and public datasets- Database design and development- Programming: Visual Basic, SQL Server, R, Bioconducter- Scientific communication: Presenting complex scientific concepts to diverse audiencesPersonal website: www.ryanvanlaar.com
Listed skills include Genomics, Genetics, Bioinformatics, Biotechnology, and 45 others.
Ryan Van Laar Ph.D.'s current company
Company context helps verify the profile and gives searchers a useful next step.
Ryan Van Laar Ph.D. work experience
A career timeline built from the work history available for this profile.
Founder & Ceo
Geneseq Biosciences is the product of 20+ years in the field of cancer genomics, assay development and delivery of clinical services. Continuous technological advances, coupled with lessons learned along the way, have inspired me to pursue a goal of highly accurate and widely available, genomic tools to help doctors diagnose and improve the lives of people.
Laboratory Director, Vice President, Research And Operations
Main functions: Provide overall direction and management of Signal Genetics’ laboratory operations, evaluate and implement new technologies, manage change and process improvement work. With the help of an outstanding team, I ensure the reliability and quality of Signal Genetics' proprietary microarray based "MyPRS" assay. This multi-gene assay combines.
Head Of Bioinformatics & New Product Development
Signal Genetics provides detailed, personalized diagnostic results that can assist cancer patients and their physicians in determining the best course of treatment.As Head of Bioinformatics & New Product Development I am overseeing a growing team of analysts and also supervising our CLIA approved laboratory in Little Rock, Arkansas. We are implementing new.
Founder
ChipDX develops and delivers novel multi-gene diagnostic and prognostic assays for oncology. The aim of the company is to increase access to advanced, well-validated predictive and prognostic assays, through collaborations with existing diagnostic service providers and also through our modular, online HIPAA-compliant genomic data analysis platform.
Bioinformatics Scientist, Oncology & Angiogenesis Department
Genomic data analysis and interpretation for high throughput oncology and angiogenesis projects, including collaborative identification of novel therapeutic targets. Sourcing and management of large-scale multi tissue genomic and clinical datasets. Modeling and prediction of potential toxicity, tissue recovery and dose-response for a range of novel.
Senior Bioinformatician
Development of novel diagnostic and prognostic multi-gene assays for cancer using custom gene expression microarrays & machine learning algorithms. Experience with internally-developed and externally sourced assays for breast, colon and unknown primary cancer. Bioinformatics, biostatistics, database development and programming. Quality control and.
Bioinformatics Research Assistant
Melbourne, Australia2 years in Pathology Department (Research Assistant) 3 years in Research Department (Bioinformatics Development & Support).* Microarray data analysis, data management, assessment of new software algorithms and tools, database & web site development.* Genomic data analysis training, manuscript and patent preparation, conference.
Research & Communications Department Assistant
I began working at the CSIRO Animal Health laboratory as a part time communications department intern, helping with the preparation of print and web-based scientific information. After this I became a laboratory research assistant role in the Immunology department, working on a range of projects, including characterization of the Hendra virus attachment.
Ryan Van Laar Ph.D. education
Postgraduate Certificate, Biostatistics
Phd, Biotechnology, Molecular Oncology
Bsc (Hons), Biotechnology
Frequently asked questions about Ryan Van Laar Ph.D.
Quick answers generated from the profile data available on this page.
What company does Ryan Van Laar Ph.D. work for?
Ryan Van Laar Ph.D. works for Geneseq Biosciences Pty Ltd.
What is Ryan Van Laar Ph.D.'s role at Geneseq Biosciences Pty Ltd?
Ryan Van Laar Ph.D. is listed as Founder and CEO at Geneseq Biosciences Pty Ltd.
What is Ryan Van Laar Ph.D.'s email address?
AeroLeads has found 1 work email signal at @signalgenetics.com for Ryan Van Laar Ph.D. at Geneseq Biosciences Pty Ltd.
What is Ryan Van Laar Ph.D.'s phone number?
AeroLeads has found 3 phone signal(s) with area code 212, 140 for Ryan Van Laar Ph.D. at Geneseq Biosciences Pty Ltd.
Where is Ryan Van Laar Ph.D. based?
Ryan Van Laar Ph.D. is based in Melbourne, Victoria, Australia while working with Geneseq Biosciences Pty Ltd.
What companies has Ryan Van Laar Ph.D. worked for?
Ryan Van Laar Ph.D. has worked for Geneseq Biosciences Pty Ltd, Signal Genetics, Inc, Chipdx Llc, Regeneron Pharmaceuticals, and Agendia.
How can I contact Ryan Van Laar Ph.D.?
You can use AeroLeads to view verified contact signals for Ryan Van Laar Ph.D. at Geneseq Biosciences Pty Ltd, including work email, phone, and LinkedIn data when available.
What schools did Ryan Van Laar Ph.D. attend?
Ryan Van Laar Ph.D. holds Postgraduate Certificate, Biostatistics from University Of Melbourne.
What skills is Ryan Van Laar Ph.D. known for?
Ryan Van Laar Ph.D. is listed with skills including Genomics, Genetics, Bioinformatics, Biotechnology, Cancer, Oncology, Biomarkers, and Life Sciences.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial